1. Home
  2. PSNL vs DGICA Comparison

PSNL vs DGICA Comparison

Compare PSNL & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • DGICA
  • Stock Information
  • Founded
  • PSNL 2011
  • DGICA 1986
  • Country
  • PSNL United States
  • DGICA United States
  • Employees
  • PSNL N/A
  • DGICA N/A
  • Industry
  • PSNL Medical Specialities
  • DGICA Property-Casualty Insurers
  • Sector
  • PSNL Health Care
  • DGICA Finance
  • Exchange
  • PSNL Nasdaq
  • DGICA Nasdaq
  • Market Cap
  • PSNL 854.8M
  • DGICA 705.0M
  • IPO Year
  • PSNL 2019
  • DGICA N/A
  • Fundamental
  • Price
  • PSNL $8.86
  • DGICA $18.83
  • Analyst Decision
  • PSNL Strong Buy
  • DGICA Hold
  • Analyst Count
  • PSNL 5
  • DGICA 1
  • Target Price
  • PSNL $8.70
  • DGICA $18.00
  • AVG Volume (30 Days)
  • PSNL 1.3M
  • DGICA 116.4K
  • Earning Date
  • PSNL 11-04-2025
  • DGICA 10-30-2025
  • Dividend Yield
  • PSNL N/A
  • DGICA 3.88%
  • EPS Growth
  • PSNL N/A
  • DGICA 219.92
  • EPS
  • PSNL N/A
  • DGICA 2.38
  • Revenue
  • PSNL $80,317,000.00
  • DGICA $987,826,050.00
  • Revenue This Year
  • PSNL N/A
  • DGICA $2.26
  • Revenue Next Year
  • PSNL $29.83
  • DGICA $3.46
  • P/E Ratio
  • PSNL N/A
  • DGICA $7.89
  • Revenue Growth
  • PSNL 0.36
  • DGICA 0.89
  • 52 Week Low
  • PSNL $2.83
  • DGICA $14.17
  • 52 Week High
  • PSNL $10.95
  • DGICA $21.12
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 52.03
  • DGICA 47.16
  • Support Level
  • PSNL $9.40
  • DGICA $18.13
  • Resistance Level
  • PSNL $10.06
  • DGICA $19.49
  • Average True Range (ATR)
  • PSNL 0.89
  • DGICA 0.40
  • MACD
  • PSNL -0.18
  • DGICA -0.08
  • Stochastic Oscillator
  • PSNL 10.20
  • DGICA 53.31

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: